Purchase Order W911SR22P0013

This is a firm fixed-price purchase order contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Research Corp Technologies Inc. for the renewal of a Pichia license. The purpose is to provide the vendor with access to proprietary cell bank information and derivative data for use in the development of a botulinum toxin vaccine. The contract has a ceiling value of $45,000.00 and a performance period ending on January 30, 2027. This contract does not have a...

This is a $28,836,234.91 firm fixed price contract awarded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract is for stability testing of critical material lots for the rBV A/B and rF1V vaccine programs, which are in advanced development to protect against botulism and pneumonic plague. The contract has a completion date of December 15, 2027. Dynport Vaccine Company...

This is a firm fixed-price contract awarded by the U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The contract is for transition, storage, inventory, retrieval, distribution, and disposal services for government-owned biological and pharmaceutical materials, including vaccines, drugs, biologics, and laboratory/clinical samples. The contract has a...

This is a cost-reimbursement contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Battelle Memorial Institute (Battelle), a non-profit organization and manufacturer of goods, to acquire services for the development of a parenteral challenge model of systemic botulinum neurotoxin intoxication in rabbits. The purpose is to support the advancement of candidate therapeutic medical countermeasures. The contract has a ceiling value of $705,524.00 and a completion...

This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Cytodel Inc., a self-certified small disadvantaged business, for the development of post-symptomatic antidotes to botulinum neurotoxin (PSABS). The $1,429,034 contract is set aside for small businesses and is part of DARPA's SBIR (Small Business Innovation Research) Phase II program. Cytodel specializes in developing recombinant botulinum toxin derivatives and has received prior grant...

This is a $82,499.02 firm fixed-price contract awarded by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), a defense agency, to Brhms LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I award under Topic #CBD181-007. SBIR Phase I awards fund the exploration of the technical merit or feasibility of an idea or technology. The contract has a completion date of April 14, 2019. This contract is a standalone award...

This is a definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to the Institute of Advanced Sciences Inc., a non-profit organization, for the development of small molecule drug candidates against botulism. The contract has a ceiling value of $350,188.19 and was awarded on September 4, 2015, with a completion date of December 7, 2015. The contract was not set aside for any specific type of business. This contract appears to be focused on the research and development of medical...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $627,627.92 definitive contract to Nature's Toolbox Inc., doing business as Biotechnology, a subsidiary of Nature's Toolbox, Inc., for research and development of a novel, rapidly deployable RNA vaccine production platform under AOI #21 Vaccines on Demand. The firm fixed price contract will be performed in Mexico over a period of approximately two years, from April 2023 through...

This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Celltheon Corporation, a small disadvantaged business, for the delivery of over 4 grams of anti-carfentanil monoclonal antibody (mAb) by June 1, 2025. The contract, valued at $60,000.00, supports research efforts by the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) under an Interagency Agreement with the National Institutes of Health (NIH) and the University of Washington. The mAb is...